Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Albert Von Rohr"'
Publikováno v:
Swiss Medical Weekly, Vol 142, Iss 1718 (2012)
Previous studies have shown that retreatment of relapsed/refractory multiple myeloma (MM) with a second course of bortezomib therapy could be effective in heavily pre-treated patients. In this study, the results of a multicentre, retrospective survey
Externí odkaz:
https://doaj.org/article/160a427a86c24352b02db01ab210d785
Autor:
Reinhard Zenhäusern, Albert Von Rohr, Kaspar Rufibach, Max Solenthaler, Sandrine Meyer-Monard, Alois Gratwohl, Urs Hess, Mario J. Bargetzi, Tibor Kovacsovic, Leda Leoncini, Andreas Tobler, null for the Swiss Group for Clinical Ca
Publikováno v:
Leukemia & Lymphoma. 50:133-136
Hairy cell leukemia (HCL) is a B-cell chronic lymphoproliferative disorder that accounts for about 2% of all leukemias. Infiltration by hairy cells is usually present in the bone marrow and spleen,...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::09eed206bf03eaada033b1995eab992c
https://doi.org/10.1080/10428190802527681
https://doi.org/10.1080/10428190802527681
Publikováno v:
Swiss medical weekly. 142
Summary Previous studies have shown that retreatment of relapsed/ refractory multiple myeloma (MM) with a second course of bortezomib therapy could be effective in heavily pretreated patients. In this study, the results of a multicentre, retrospectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::470a55ecc81ad6625f9ef1bcadd72c02
https://pubmed.ncbi.nlm.nih.gov/22544478
https://pubmed.ncbi.nlm.nih.gov/22544478
Autor:
Albert von Rohr, Francesco Zappa, Michael Giger, Ralf Brunner, Claudius Irlé, Domenique Piguet, Peter Ahnesorg, R. A. Popescu
Publikováno v:
Acta haematologica. 123(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35b68597ed8fe384c721f002c1ffda12
https://pubmed.ncbi.nlm.nih.gov/20145388
https://pubmed.ncbi.nlm.nih.gov/20145388
Autor:
Martin Oberholzer, Michael Kurrer, Beatrice Wagner, Shu-Fang Hsu-Schmitz, Albert Von Rohr, Audrey S. Baur, Nina Hurwitz, Paulette Mhawech-Fauceglia, Senait Aschenafi, Françoise Delacrétaz
Publikováno v:
Archives of pathologylaboratory medicine. 130(3)
Context.—Minimal residual disease (MRD) in patients treated for hairy cell (HC) leukemia as assessed by immunohistochemistry has not been included routinely in evaluation of treatment results. Objective.—To assess the presence of persistent HCs a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b7f4f25bb82d36aca8b3f08d52a1227
https://pubmed.ncbi.nlm.nih.gov/16519567
https://pubmed.ncbi.nlm.nih.gov/16519567
Autor:
Nick Thatcher, Albert Von Rohr
Publikováno v:
The role of interleukin-2 in the treatment of cancer patients ISBN: 9789401047692
Most malignant tumours are still incurable in advanced stages. Surgery and radiotherapy certainly have an established role, but systemic treatment, usually chemotherapy, is considered standard treatment for disseminated malignancies. The activity of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f146511b1b7f1b71c4ac28eb9954ea73
https://doi.org/10.1007/978-94-011-1753-1_7
https://doi.org/10.1007/978-94-011-1753-1_7
Autor:
Christian Taverna, Jerome Voegeli, Irena Hrusovsky, Berthold Emmerich, Claas Frohn, Albert von Rohr, Robert Olie, Georg Hess, Harold Pliskat, Monika Engelhardt
Publikováno v:
Blood. 112:2775-2775
In myeloma therapy retreatment after successful therapy is frequently considered. Here we present pooled data from a German and Swiss multicenter, retrospective survey (26866138MMY4014). The survey started in Germany and was later extended to Switzer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ece01803a21f85279a345a83c1b0689b
https://doi.org/10.1182/blood.v112.11.2775.2775
https://doi.org/10.1182/blood.v112.11.2775.2775